StockData
Edwards Lifesciences Corp logo

Edwards Lifesciences Corp

EWNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 10/3056% above fair value
$101.85−2.03 (-1.95%)

Close on Nov 20, 2026Market cap $58.71BP/E 58.5Yield –

Edwards Lifesciences Operating Cash Flow by Quarter

Operating Cash Flow (Net Cash Provided by Operating Activities) ($M)

Edwards Lifesciences Operating Cash Flow: $570M in Q3 2026, down 0.6% from a year earlier.

Latest, Q3 2026
570
Period ended Sep 30, 2026
Change on a year earlier
-0.6%
574 in Q3 2025
History
69 quarters
Since Q3 2009
Sources
54
Documents cited below

Where the Q3 2026 figure comes from

Calculated from reported figures: quarter = year-to-date − previous year-to-date (cash flow statement)

Source: Form 10-Q (filed 2026-11-04) ↗

Reported in Form 10-K / Form 10-Q Consolidated Statements of Cash Flows.

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedOperating Cash Flow (Net Cash Provided by Operating Activities) ($M)Year on yearSource
Q3 2026Sep 30, 2026570-0.6%Form 10-Q (filed 2026-11-04) ↗
Q2 2026Jun 30, 2026652+124.6%Form 10-Q (filed 2026-08-04) ↗
Q1 2026Mar 31, 202643.8-84.4%Form 10-Q (filed 2026-05-06) ↗
Q4 2025Dec 31, 2025451-453.6%Form 10-K (filed 2026-02-25) ↗
Q3 2025Sep 30, 2025574+63.1%Form 10-Q (filed 2025-11-05) ↗
Q2 2025Jun 30, 2025290-21.9%Form 10-Q (filed 2025-08-06) ↗
Q1 2025Mar 31, 2025280-624.1%Form 10-Q (filed 2025-05-06) ↗
Q4 2024Dec 31, 2024-128-193.3%Form 10-K (filed 2025-02-28) ↗
Q3 2024Sep 30, 2024352-14.5%Form 10-Q (filed 2024-11-06) ↗
Q2 2024Jun 30, 2024372+1,005.7%Form 10-Q (filed 2024-07-31) ↗
Q1 2024Mar 31, 2024-53.5-117.0%Form 10-Q (filed 2024-04-29) ↗
Q4 2023Dec 31, 2023137-51.7%Form 10-K (filed 2024-02-12) ↗
Q3 2023Sep 30, 2023412+32.8%Form 10-Q (filed 2023-10-27) ↗
Q2 2023Jun 30, 202333.6-89.9%Form 10-Q (filed 2023-07-28) ↗
Q1 2023Mar 31, 2023314+7.1%Form 10-Q (filed 2023-04-28) ↗
Q4 2022Dec 31, 2022283-24.3%Form 10-K (filed 2023-02-13) ↗

Breakdown

What makes up operating Cash Flow

Cite this data

StockData. (2026). Edwards Lifesciences Operating Cash Flow ($M), quarterly Q3 2009–Q3 2026 [Data set]. Compiled from Edwards Lifesciences SEC filings and investor materials. https://stockdatahq.com/stocks/ew/kpis/db-fin-ocf

See every metric in the Edwards Lifesciences KPI table. Data updated Nov 7, 2026.

See a number that looks wrong?